BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Rolitetracycline

A pyrrolidinylmethyl TETRACYCLINE.

166+ PubMed studies analyzed · 2 RCTs · Evidence Score: 44.1

Research Domains

Rolitetracycline has been studied across 15 research domains including 🫁 Liver & Detox, 🧠 Focus & Attention, ❤️ Cardiovascular, 🫁 Respiratory, 🏋️ Muscle & Hypertrophy. The primary research focus is 🫁 Liver & Detox with 6% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Rolitetracycline, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Lymecycline
3 shared targets
Droxidopa
2 shared targets
piroxicam
2 shared targets
ketoprofen
2 shared targets
sc
2 shared targets
sinapinate
2 shared targets
suprofen
2 shared targets
bromfenac
2 shared targets
sc
2 shared targets
lumiracoxib
2 shared targets
Loading evidence profile...

This evidence profile for Rolitetracycline is generated deterministically from 166 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.